Functional Significance of Nuclear Estrogen Receptor Subtypes in the Liver of Goldfish

被引:113
|
作者
Nelson, Erik R. [2 ]
Habibi, Hamid R. [1 ]
机构
[1] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada
[2] Duke Univ, Med Ctr, Durham, NC 27710 USA
基金
加拿大自然科学与工程研究理事会;
关键词
CARASSIUS-AURATUS; ER-BETA; RAINBOW-TROUT; TISSUE DISTRIBUTION; MOLECULAR-CLONING; BINDING DOMAIN; MESSENGER-RNA; ALPHA; EXPRESSION; IDENTIFICATION;
D O I
10.1210/en.2009-1447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogens work by binding to and activating specific estrogen receptors (ERs). Although mammals have two major nuclear ER subtypes (ER alpha and ER beta), three subtypes have been shown in teleost fish (ER alpha, ER beta-I, and ER beta-II). 17 beta-Estradiol stimulates the production of an egg yolk precursor protein (vitellogenin) in the liver of oviparous species, including the goldfish. However, the functional involvement of the ER subtypes in this process is not fully understood. Here, using primary goldfish hepatocytes, we test the hypothesis that all three ER subtypes are functionally involved in the liver of goldfish by using RNA interference to specifically knock-down the different ER subtypes. The results suggest that ER alpha is induced by estradiol through activation of the ER beta subtypes. This induction serves to sensitize the liver to further stimulation by estradiol. The knock-down results were supported by use of ER subtype specific antagonists. Sensitization by up-regulation of ER alpha is likely to be important for seasonal spawners such as goldfish, to bring about a change from somatic growth to reproductive development, and vitellogenesis. The novel data presented in this study provide strong support for the hypothesis that the goldfish ER subtypes play functional roles in the regulation of vitellogenin and ER alpha and provide a framework for the better understanding of ER signaling in fish and other vertebrates. (Endocrinology 151: 1668-1676, 2010)
引用
收藏
页码:1668 / 1676
页数:9
相关论文
共 50 条
  • [21] Functional significance of a truncated thyroid receptor subtype lacking a hormone-binding domain in goldfish
    Nelson, Erik R.
    Habibi, Hamid R.
    ENDOCRINOLOGY, 2008, 149 (09) : 4702 - 4709
  • [22] The clinical and pathogenetic significance of estrogen receptor-β expression in chronic liver diseases and liver carcinoma
    Iavarone, M
    Lampertico, P
    Seletti, C
    Donato, MF
    Ronchi, G
    Del Ninno, E
    Colombo, M
    CANCER, 2003, 98 (03) : 529 - 534
  • [23] CALCITONIN RECEPTOR SUBTYPES AND THEIR BIOLOGICAL SIGNIFICANCE
    NAKAMUTA, H
    KOIDA, M
    ORLOWSKI, RC
    EPAND, RM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (02) : 501 - 501
  • [24] Auto-regulation of estrogen receptor subtypes and gene expression profiling of 17β-estradiol action in the neuroendocrine axis of male goldfish
    Marlatt, V. L.
    Martyniuk, C. J.
    Zhang, D.
    Xiong, H.
    Watt, J.
    Xia, X.
    Moon, T.
    Trudeau, V. L.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 283 (1-2) : 38 - 48
  • [25] SUBTYPES OF GABA RECEPTOR - THEIR PROPERTIES AND SIGNIFICANCE
    KURIYAMA, K
    TAGUCHI, J
    TOMONOH, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 1985, 39 : P34 - P34
  • [26] The significance of serotonin receptor subtypes for psychiatry
    Broekkamp, C
    ACTA NEUROPSYCHIATRICA, 1997, 9 (01) : 20 - 26
  • [27] Regulation of estrogen receptor subtypes on vascular cells
    Geraldes, P
    Sirois, MG
    Tanguay, JF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 250A - 250A
  • [28] The role of estrogen receptor subtypes for vascular maintenance
    Luksha, Leanid
    Kublickiene, Karolina
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (02) : 82 - 95
  • [29] Estrogen receptor subtypes and afferent signaling in the bladder
    Schröder, A
    Pandita, RK
    Hedlund, P
    Warner, M
    Gustafsson, JA
    Andersson, KE
    JOURNAL OF UROLOGY, 2003, 170 (03): : 1013 - 1016
  • [30] Estrogen Receptors: Therapies Targeted to Receptor Subtypes
    Nilsson, S.
    Gustafsson, J-A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (01) : 44 - 55